ProAssurance (NYSE:PRA – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “sell” rating in a research report issued on Saturday.
Several other equities analysts also recently commented on PRA. Weiss Ratings reaffirmed a “hold (c)” rating on shares of ProAssurance in a research note on Wednesday, October 8th. Zacks Research lowered ProAssurance from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. Five analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $25.00.
Read Our Latest Report on ProAssurance
ProAssurance Stock Performance
ProAssurance (NYSE:PRA – Get Free Report) last issued its earnings results on Friday, May 20th. The insurance provider reported $0.04 EPS for the quarter. The company had revenue of $220.02 million for the quarter. ProAssurance had a net margin of 4.33% and a return on equity of 5.62%. Analysts expect that ProAssurance will post 0.8 earnings per share for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in the company. CWM LLC boosted its position in shares of ProAssurance by 95.9% during the first quarter. CWM LLC now owns 2,204 shares of the insurance provider’s stock valued at $51,000 after purchasing an additional 1,079 shares in the last quarter. Victory Capital Management Inc. purchased a new position in ProAssurance during the first quarter valued at $209,000. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of ProAssurance during the 1st quarter valued at $224,000. XTX Topco Ltd purchased a new stake in shares of ProAssurance in the 1st quarter worth about $319,000. Finally, Alpine Associates Management Inc. purchased a new stake in shares of ProAssurance in the 1st quarter worth about $5,167,000. Institutional investors own 85.58% of the company’s stock.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
See Also
- Five stocks we like better than ProAssurance
- What is the Dogs of the Dow Strategy? Overview and Examples
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- P/E Ratio Calculation: How to Assess Stocks
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- Upcoming IPO Stock Lockup Period, Explained
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.
